Norges Bank Purchases New Shares in Healthpeak Properties, Inc. (NYSE:DOC)

Norges Bank bought a new stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm bought 8,229,093 shares of the real estate investment trust's stock, valued at approximately $166,804,000. Norges Bank owned 1.18% of Healthpeak Properties as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Harvest Fund Management Co. Ltd bought a new position in Healthpeak Properties during the 4th quarter worth approximately $30,000. Groupama Asset Managment acquired a new position in shares of Healthpeak Properties during the third quarter worth approximately $37,000. Continuum Advisory LLC bought a new stake in shares of Healthpeak Properties during the third quarter worth about $44,000. AdvisorNet Financial Inc lifted its position in Healthpeak Properties by 34.5% in the 4th quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust's stock valued at $44,000 after acquiring an additional 563 shares in the last quarter. Finally, Kestra Investment Management LLC acquired a new position in Healthpeak Properties during the 4th quarter valued at about $45,000. Institutional investors and hedge funds own 93.57% of the company's stock.

Analysts Set New Price Targets

A number of research firms recently commented on DOC. Mizuho lowered their price target on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a research report on Thursday, December 5th. Wells Fargo & Company reduced their price objective on shares of Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating for the company in a research report on Tuesday, December 10th. Wedbush reduced their target price on Healthpeak Properties from $27.00 to $24.00 and set an "outperform" rating for the company in a report on Friday, February 14th. Scotiabank dropped their price target on Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating on the stock in a report on Friday, February 28th. Finally, Robert W. Baird lowered their target price on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating on the stock in a research note on Tuesday, February 11th. Four investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Healthpeak Properties currently has an average rating of "Moderate Buy" and a consensus target price of $23.83.

Remove Ads

Healthpeak Properties Trading Down 4.2 %

Shares of NYSE DOC traded down $0.82 during trading hours on Friday, hitting $18.65. The company's stock had a trading volume of 2,898,241 shares, compared to its average volume of 4,841,357. Healthpeak Properties, Inc. has a 12 month low of $17.80 and a 12 month high of $23.26. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35. The business has a 50-day simple moving average of $20.16 and a 200-day simple moving average of $21.04. The stock has a market cap of $13.04 billion, a price-to-earnings ratio of 53.33, a P/E/G ratio of 2.17 and a beta of 1.14.

Healthpeak Properties Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th were given a dividend of $0.305 per share. This is an increase from Healthpeak Properties's previous quarterly dividend of $0.30. This represents a $1.22 dividend on an annualized basis and a yield of 6.54%. The ex-dividend date was Friday, February 14th. Healthpeak Properties's payout ratio is presently 348.57%.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.